The Platform

The QuartzBioSM advantage

  • Unrivaled speed and assimilation of all biomarker data from high-content to high-throughput
  • Transparent, immediate insight into all layers of the harmonized biomarker data
  • Visibility into the hierarchical nature of biological data (eg, access to raw images, gating schema for flow cytometry data, and more)
  • Access to the depth of biomarker data and contextual information
  • Exploration at an unprecedented rate, enabling you to assess PD effects, guide dose selection, and stratify patients more efficiently

QuartzBioSM capabilities

Access all of your biomarker and key clinical data at the click of a mouse—in a single, secure cloud-based solution that is 21 CFR Part 11 compliant

QuartzBio technology platform for translational research


Technology rapidly surfaces the utility of complex data

The QuartzBio platform manages complex biomarker data and delivers it in a format you can use to advance your research. The platform rapidly assimilates data, then offers advanced visualization, analysis, secure access, and on-demand reporting—all in compliance with 21 CFR Part 11 standards.

A single phase 1 study may encompass more than 10 million data points—that’s why we created QuartzBio. This unprecedented platform can address an array of biomarker assay technologies simultaneously, no matter how high-content or high-throughput the data may be. Complex flow cytometry. Immunosequencing. Next generation sequencing. QuartzBio can handle them all—and more.

Precision for Medicine supports life sciences companies in the use of biomarkers essential to targeting patients more precisely and effectively. Precision applies novel biomarker approaches to clinical research that take advantage of the latest advancements in science and technology, focusing predominantly on genomics, immune-response assays, global specimen logistics, biomarker analytics, companion diagnostics, and clinical trial execution.